Inventor · disambiguated record
Yuji Hori
Also filed as: HORI YUJI
11 granted patents·5 pending applications·91 citations·filing 2015–2025
89Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD16
Top patents by PatentIndex Score
16 records- 0197US11142587B2Method for producing polypeptide hetero-oligomerCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 12, 2021·13 cites·14 claims
- 0296US11454633B2Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Sep 27, 2022·4 cites·19 claims
- 0396US10738111B2Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 11, 2020·17 cites·25 claims
- 0496US10000560B2Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 19, 2018·26 cites·43 claims
- 0594US10519229B2Nucleic acids encoding IL-8 antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 31, 2019·22 cites·33 claims
- 0693US11180548B2Methods of neutralizing IL-8 biological activityCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 23, 2021·6 cites·11 claims
- 0787US2025076311A1Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0883US12304960B2Anti-CD137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 20, 2025·3 cites·27 claims
- 0977US12415857B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·21 claims
- 1072US12359001B2Method for producing polypeptide hetero-oligomerCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 15, 2025·0 cites·24 claims
- 1171US12448451B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Oct 21, 2025·0 cites·20 claims
- 1270US2023203144A1Combination of two or more anti-c5 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1367US12169205B2Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 17, 2024·0 cites·5 claims
- 1462US2023058982A1Anti-ctla-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1562US2025388689A1Anti-cd137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1643US2018016327A1A Combination of Two or More Anti-C5 Antibodies and Methods of UseCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuji Hori files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →